Clinical Trials Browser

Interventional × Papillomavirus Infections × 90 days × Clear all

NCT06738355 2026-06-05

PREVENT Pilot HPV - Related Cancers Trial

Phase NA Completed

Vaccination Refusal, Behavior, Communication, Neoplasms, Patient Acceptance of Health Care, Papillomavirus Infections

NCT07217145 2026-06-05

PREVENT HPV -Related Cancers Trial

Phase 3 Active not recruiting

Behavior, Communication, Neoplasms, Patient Acceptance of Health Care, Papillomavirus Infections

NCT06784960 2026-06-04

Communication Strategies to Increase HPV Vaccination Intention

Phase NA Completed

Vaccination Hesitancy, Communication, Papillomavirus Infections

NCT07209917 2026-06-04

SAKHI

Phase NA Recruiting

Acquired Immunodeficiency Syndrome, Uterine Cervical Neoplasms, Infections, Papillomavirus Infections

NCT07624123 2026-06-03

C-3001B-P-CS7

Phase NA Not yet recruiting

17,734 enrolled

Uterine Cervical Neoplasms, HIV Infections, Papillomavirus Infections

NCT03998254 2026-06-02

V503-023

Phase 3 Active not recruiting

Papillomavirus Infections

NCT07545746 2026-06-02

ASCEND

Phase 2 Not yet recruiting

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, HIV Infections, Papillomavirus Infections

NCT03036930 2026-05-29

Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients

Phase 2 Active not recruiting

51 enrolled 10 charts

Papillomavirus Infections

NCT05797246 2026-05-29

Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)

Phase 2 Active not recruiting

DNA Virus Infections, Infections, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Glandular and Epithelial, Papilloma, Pathologic Processes, Recurrence, Respiratory Tract Diseases, Respiratory Tract Infections, Tumor Virus Infections, Virus Diseases, Neoplasms, Squamous Cell, Disease Attributes, Papillomavirus Infections

NCT06380114 2026-05-29

Stand Up 2 HPV: Standing Orders to Improve HPV Vaccination

Phase NA Recruiting

16,000 enrolled

Papillomavirus Infections

NCT07614009 2026-05-29

THE EFFECTS OF HPV VACCİNATİON AND MESSAGE FRAMİNG

Phase NA Completed

Papillomavirus Infections

NCT07428330 2026-05-28

CASCADE3001A

Phase NA Recruiting

Uterine Cervical Neoplasms, HIV Infections, Papillomavirus Infections

NCT06210854 2026-05-27

Assessing Administration of pBI-11 Via Electroporation for the Treatment of Patients With HPV16/18+

Phase 2 Not yet recruiting

Papillomavirus Infections

NCT05935644 2026-05-22

ORCHID-Miami

Phase NA Suspended

Acquired Immunodeficiency Syndrome, Depression, Papillomavirus Infections

NCT06162676 2026-05-20

Game-Based Intervention to Promote HPV Vaccination

Phase NA Completed

Vaccine-Preventable Diseases, Papillomavirus Infections

NCT06959563 2026-05-20

9vHPV-BCG

Phase EARLY_PHASE1 Active not recruiting

Papillomavirus Infections

NCT07572396 2026-05-14

Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytologic Abnormalities

Phase 2 Recruiting

Squamous Intraepithelial Lesions, Uterine Cervical Dysplasia, Papillomavirus Infections, Atypical Squamous Cells of the Cervix

NCT06498661 2026-05-13

SHIP-A-S01

Phase NA Active not recruiting

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT06611540 2026-05-13

LMI-001-A-S03

Phase NA Active not recruiting

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT06611553 2026-05-13

LMI-001-A-S02

Phase NA Active not recruiting

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT07281430 2026-05-13

LMI-001-A-S04

Phase NA Recruiting

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT03726151 2026-05-12

Comparative Effectiveness of System Interventions to Increase HPV Vaccine Receipt in FQHCs

Phase NA Completed

17,000 enrolled

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT07578467 2026-05-11

Combining Neo-adjuvant ATR-inhibition With Nodal SBRT for Early-stage Resectable HPV+ OPSCCs

Phase 1/2 Not yet recruiting

Carcinoma, Squamous Cell, Papillomavirus Infections

NCT04235257 2026-05-05

Intradermal, Fractional Dose of HPV Vaccines:

Phase 4 Active not recruiting

Papillomavirus Infections

NCT05291871 2026-05-05

Immunogenicity of Fractional Dose of the HPV Vaccines

Phase 4 Active not recruiting

Papillomavirus Infections

NCT06598475 2026-05-04

Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve Provider Recommendation and HPV Vaccination Rates Among Latino/a Adolescents

Phase NA Recruiting

Papillomavirus Infections

NCT04206813 2026-04-29

An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen

Phase 4 Active not recruiting

Papillomavirus Infections

NCT07557719 2026-04-29

Gamified Learning Methods and HPV Knowledge in Nursing Students

Phase NA Active not recruiting

Papillomavirus Infections

NCT07550010 2026-04-24

Digital Telecytology for Triage of HPV-Positive Women in Cameroon

Phase NA Recruiting

Papillomavirus Infections

NCT07209189 2026-04-23

(NeoScorch HN)

Phase 2 Recruiting

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms, Papillomavirus Infections

NCT07453459 2026-04-23

Feasibility of HPV Self-Collection Kits for Cervical Cancer Screening

Phase NA Recruiting

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT07521163 2026-04-15

HBM-HPV

Phase NA Not yet recruiting

Uterine Cervical Neoplasms, Health Education, Papillomavirus Infections

NCT07200414 2026-04-13

SHARP

Phase NA Completed

12,654 enrolled

Infections, Papillomavirus Infections

NCT03903562 2026-04-06

V503-024

Phase 3 Completed

1,990 enrolled 42 charts

Papillomavirus Infections

NCT01898494 2026-04-01

Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer

Phase 2 Active not recruiting

519 enrolled 16 charts

Squamous Cell Carcinoma of Head and Neck, Oropharyngeal Neoplasms, Papillomavirus Infections

NCT04226313 2026-03-23

KOPRETINA

Phase NA Recruiting

15,000 enrolled

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections

NCT06256718 2026-03-17

Implementation of Evidence-Based Strategy (PC TEACH) for the Optimization of HPV Vaccination in Rural Primary Care

Phase NA Active not recruiting

Papillomavirus Infections